HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced May 17th this year that the National Institute of Allergy and Infectious…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.